Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience. Arch Ital Urol Androl [Internet]. 2022 Dec. 27 [cited 2026 May 12];94(4):413-9. Available from: https://www.pagepressjournals.org/aiua/article/view/10934